IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Rednex Pharmaceuticals
IPO is a SME Upcoming IPO coming on
BSE SME with an
IPO
size of
[●]
.
This IPO falls under the
Pharmaceutical sector, which has seen
42 IPOs
to date. Key sector metrics such as average PE ratio, IPO size, EBITDA margin,
and
PAT margin are compared below with the figures from the
Rednex Pharmaceuticals
IPO.
Rednex Pharmaceuticals IPO Peer Comparison with key metrics mentioned in the DRHP.
| Company Name | CMP | FV | Basic EPS | Diluted EPS | PE | RoNW % | Book Value | Total Income |
|---|---|---|---|---|---|---|---|---|
| Rednex Pharmaceuticals Limited | 10 | 5.57 | 5.57 | 45.02 | 22.28 | 46.12 | ||
| Medico Remedies Limited | 48.84 | 2 | 1.22 | 1.22 | 40.03 | 16.16 | 7.53 | 153.63 |
| Sakar Healthcare Limited | 366.70 | 10 | 7.97 | 7.95 | 46.13 | 6.19 | 128.75 | 178.90 |
Source-All the financial information for listed industry peers are sourced from their audited financial results for the year ended March 31, 2025 as available on the stock exchange.
Market Price for the listed peer mentioned above is sourced from stock exchange data dated September 25, 2025 to compute the corresponding financial ratios. For our Company, we have taken Current Market Price as the issue price of equity share.
Further, P/E Ratio is based on the current market price of the respective scrips.
The EPS, NAV, RoNW and Total Income of our Company are taken as per Restated Financial Statement for the Financial Year 2024-25 as adjusted with the effect of Bonus Issue.
NAV per share is computed as the closing net worth divided by the closing outstanding number of paid-up equity shares as adjusted with the effect of Bonus Issue.
P/E Ratio of the peer company is sourced from their audited financial results for the year ended March 31, 2025 and stock exchange data dated September 25, 2025
RoNW has been computed as net profit after tax divided by closing net worth.
Net worth has been computed in the manner as specifies in Regulation 2(1) (hh) of SEBI (ICDR) Regulations, 2018.
The face value of Equity Shares of our Company is ₹ 10/- per Equity Share and the Issue price is [●] times the face value of equity share.
You can do performance analysis for Rednex Pharmaceuticals IPO with Listed IPOs in the Pharmaceutical sector and review their IPO performance based on Merchant banker, Listing price, IPO Valuation and other metrics.
This IPO report captures the post-listing performance of IPOs in the Pharmaceutical sector, featuring key metrics like offer price, listing gain, and CMP to help investors assess return potential and sector sentiment.
Rednex Pharmaceuticals IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
The peers of
Rednex Pharmaceuticals ,
include other listed companies operating in the
(Pharmaceutical) segment. These peer companies
typically
offer similar services Some of the notable peers as per the DRHP of this
company
are
Rednex Pharmaceuticals Limited ,
Medico Remedies Limited ,
Sakar Healthcare Limited ,
.
See the complete list of
current IPO
Peer Comparison is the method of evaluating an entity by comparing its performance, size of business form other entities operating in same industry or sector. It involves financial analysis bycomparing key financial metrics like Profitability, Net worth, Market Capitalization and Leverage. Peer comparison is beneficial for investors to make informed investment decisions and to identify any potential risks. IPO Performance tracker
Peer comparison helps to identify companies in the same sector with a similar business. It helps to compare the financial performance and valuation against its listed peers. An investor or an analyst can decide whether the IPO price is justified when compared to its peers. An investor can make informed decision whether to apply to IPO or not on basis of peer comparison. Know the process of DRHP and Peer companies Information required to be disclosed in DRHP.
As of now 42 SME IPOs are listed in this sector indicating strong growth in this sector. Choosing the best IPO depends on factors like, financial performance, valuation, market trends and future growth plans. IPO Review and performance.
A good PE Ratio for Pharmaceutical sector depends on various factors like, performance of the company, market conditions, company valuation and IPO Size. PE Ratio varies from sector to sector and company to company. Know the average PE Multiple in each sector.
Currently 42 companies are listed under Pharmaceutical sector. Based on the latest data from the Stock Exchanges. Choose the Best Merchant Banker from the Merchant Banker List
Performance of companies depends on various factors like, profits, future plans, Market share, PE Ratio etc. By assessing these factors investor can make better investment decisions.Rednex Pharmaceuticals Peer comparison provides IPO analysis of companies listed in this sector, on the basis of different Key performance indicators (KPI)like, Listing Gain of peers, current market price, PE Ratio and IPO Size.
Upcoming IPO refers to companies which have filed their DRHP with the Stock exchange and are awaiting approval from NSE Emerge or BSE SME. 13 companies have filed their DRHP for SME IPO under Pharmaceutical sector. .New IPO 2025-2026 and Upcoming IPO
PE Multiple is a metrics that is widely used for IPO Valuation. Merchant bankers in coordination with the company decides the PE Multiple.The PE Multiple depends on various factors and it should be analyzed in coordination with other financial metrics. Know the PE ratio of your company with PE Calculator provided by IPOplatform
Rednex Pharmaceuticals operates in Pharmaceutical and Manufacturing Of A Wide Range Of Pharmaceutical Products. The Issue is listed on BSE SME in Oct, 2025. Rednex Pharmaceuticals IPO size was with Issue price of .
Merchant Banker(s) of Rednex Pharmaceuticals IPO: Hem Securities Limited
Rednex Pharmaceuticals IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Rednex Pharmaceuticals IPO listed at a listing price of against the offer price of .
The current market price of Rednex Pharmaceuticals is .
Why Us?
